Literature DB >> 8737156

gyrA of ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Hong Kong.

K J Williams, R Chan, L J Piddock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8737156     DOI: 10.1093/jac/37.5.1032

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

Review 1.  A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.

Authors:  Fernanda Maruri; Timothy R Sterling; Anne W Kaiga; Amondrea Blackman; Yuri F van der Heijden; Claudine Mayer; Emmanuelle Cambau; Alexandra Aubry
Journal:  J Antimicrob Chemother       Date:  2012-01-25       Impact factor: 5.790

Review 2.  Mechanisms of fluoroquinolone resistance: an update 1994-1998.

Authors:  L J Piddock
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 3.  The role of fluoroquinolones in tuberculosis today.

Authors:  S E Berning
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis.

Authors:  Federico Giannoni; Elisabetta Iona; Federica Sementilli; Lara Brunori; Manuela Pardini; Giovanni Battista Migliori; Graziella Orefici; Lanfranco Fattorini
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

Review 5.  Drug treatment for tuberculosis during pregnancy: safety considerations.

Authors:  G Bothamley
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

Review 6.  Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review.

Authors:  Elisea Avalos; Donald Catanzaro; Antonino Catanzaro; Theodore Ganiats; Stephanie Brodine; John Alcaraz; Timothy Rodwell
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

7.  Accumulation of norfloxacin by Mycobacterium aurum and Mycobacterium smegmatis.

Authors:  K J Williams; G A Chung; L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.